Hot Features
Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company was found... Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company was founded in 2016 and is headquartered in West Conshohocken, Pennsylvania. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -27.24 | -5.19887014276 | 523.96 | 529.86 | 445.2 | 319841 | 484.31469658 | CS |
| 4 | -37.38 | -6.99868938401 | 534.1 | 547.24 | 445.2 | 296844 | 509.31236969 | CS |
| 12 | 69.445 | 16.2529986543 | 427.275 | 572.195 | 421.55 | 309687 | 507.05708803 | CS |
| 26 | -85.87 | -14.7393535763 | 582.59 | 615 | 416.21 | 322456 | 503.36601643 | CS |
| 52 | 211.39 | 74.0861458662 | 285.33 | 615 | 271.955 | 341787 | 449.09330767 | CS |
| 156 | 236.72 | 91.0461538462 | 260 | 615 | 119.7604 | 386297 | 306.65613341 | CS |
| 260 | 394.19 | 384.463083975 | 102.53 | 615 | 52.33 | 340830 | 259.90760413 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.